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A P P L I E D  S C I E N C E S  A N D  E N G I N E E R I N G
Nonresonant powering of injectable nanoelectrodes 
enables wireless deep brain stimulation in freely 
moving mice
K. L. Kozielski1,2*†, A. Jahanshahi3*, H. B. Gilbert1,4, Y. Yu1, Ö. Erin1,5, D. Francisco1, F. Alosaimi3, 
Y. Temel3‡, M. Sitti1,6,7†‡
Devices that electrically modulate the deep brain have enabled important breakthroughs in the management of 
neurological and psychiatric disorders. Such devices are typically centimeter-scale, requiring surgical implanta-
tion and wired-in powering, which increases the risk of hemorrhage, infection, and damage during daily activity. 
Using smaller, remotely powered materials could lead to less invasive neuromodulation. Here, we present inject-
able, magnetoelectric nanoelectrodes that wirelessly transmit electrical signals to the brain in response to an ex-
ternal magnetic field. This mechanism of modulation requires no genetic modification of neural tissue, allows 
animals to freely move during stimulation, and uses nonresonant carrier frequencies. Using these nanoelectrodes, 
we demonstrate neuronal modulation in vitro and in deep brain targets in vivo. We also show that local subtha-
lamic modulation promotes modulation in other regions connected via basal ganglia circuitry, leading to behav-
ioral changes in mice. Magnetoelectric materials present a versatile platform technology for less invasive, deep 
brain neuromodulation.
INTRODUCTION
Electrical communication with and modulation of the central ner-
vous system (CNS) are essential to our current understanding of neu-
robiology and in the diagnosis and treatment of neurological disorders. 
Using sensing and/or modulation of neural electrical activity, key 
therapeutic CNS interventions have allowed remarkable medical 
breakthroughs. For more than 30 years, deep brain stimulation (DBS) 
has provided patients with symptom relief from Parkinson’s disease, 
as well as other disorders, using electrodes wired into deep targets 
within the brain (1). More recently, closed-loop control of epidural 
electrical stimulation enabled walking in patients with spinal cord 
injury (2). Such devices function in freely moving patients, enabling 
daily activity and chronic patient use.
In recent years, efforts to make neural intervention less invasive, 
longer-lasting, and safer have progressed the capabilities of neural 
devices [For review, see (3)]. A key challenge of such devices is powering, 
and wired-in powering can require that patients undergo surgical 
battery changes, every 3 to 5 years in the case of DBS devices (4). 
Instead, neural devices that are remotely powered have emerged 
using magnetic induction (5), optoelectronic signaling (6–8), acoustic 
powering of piezoelectric materials (9–14), magnetic heating (15), 
piezoelectric powering of light-emitting diodes (LEDs) (16, 17), or 
magnetoelectric materials (18), instead of a wired-in battery.
Similar to conventional DBS electrodes, centimeter-scale devices 
require surgery and implantation of hardware external to the CNS, 
which risks brain hemorrhage, infection, and damage during daily 
activity (4). Thus, several neural device technologies have instead 
turned to smaller (nano- to millimeter-scale) devices, which can be 
completely implanted within the CNS, potentially via injection. 
However, smaller size can make powering of neural devices more 
difficult. Remotely powered devices using magnetic induction (5) 
or optoelectronic signaling (6, 7) thus far are limited in their tissue 
penetration depth, maximally reaching 1 cm and 6 mm, respectively 
(19). Ultrasound-powered piezoelectric devices are perhaps the most 
promising of these technologies, recently showing recording at mul-
tiple sites through 5 cm of tissue phantom material with a sub-mm3 
device (10). Modulation with piezoelectric devices, however, has 
currently only been demonstrated in the peripheral nervous sys-
tem using millimeter-scale devices or in  vitro (12–14). As power 
transmission is typically done at the mechanical resonance fre-
quency of such devices, this creates a fundamental tradeoff where 
an increasingly smaller device with a higher resonance frequency 
can be powered at increasingly shallower tissue depths (20, 21). Thus, 
resonant coupling–based powering creates an obstacle to modulat-
ing deep brain targets with an injectable-sized device.
To circumvent signal transmission challenges, other strategies 
have used genetic neuronal modification and magnetothermal nano-
particles (15) or piezoelectrically powered LEDs (16, 17) to trigger 
ion channel opening. However, the dependence of such technolo-
gies on transgenesis creates regulatory barriers to their translation 
into patients. Wireless modulation of neural activity is clinically 
available using transcranial magnetic stimulation (TMS), which re-
quires no implanted device (22). However, TMS only modulates 
cortical tissue (23) and has a depth-focal area tradeoff (24, 25), mak-
ing DBS via TMS currently impossible.
To achieve wireless signal transmission to injectable devices, we 
have used magnetoelectric nanoelectrodes, which couple magnetic 
and electric signals (Fig. 1, A and B). Technologies using magneto-
electric materials for neuromodulation have previously been 
explored. Centimeter- and millimeter-scale magnetoelectric de-
vices have been used for DBS, using a device mounted to the skull 
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and wired into the deep brain (18). In another study, magnetoelec-
tric nanoparticles (MENPs) were used with the goal of achieving 
neuromodulation, although no replicates or statistical analysis was 
used to verify in vivo efficacy (26). Nevertheless, these studies 
demonstrate the promise of magnetoelectric materials for neural 
devices.
Here, we report wireless DBS in mice using injectable, magneto-
electric nanoelectrodes. They are implanted into the subtha-
lamic area via stereotactic infusion, and powered using an external 
magnetic field at nonresonant carrier frequencies and in freely 
moving mice (Fig. 1C). In particular, we made two-phase MENPs 
using magnetostrictive CoFe2O4 nanoparticles (MSNPs) coated 
Fig. 1. Material and magnetoelectric characterization of MENPs made from magnetostrictive and piezoelectric phases demonstrates wireless electric field 
generation. Schematic demonstrating two-phase magnetoelectricity in materials made from magnetostrictive and piezoelectric materials that are strain-coupled 
(A). Schematic demonstrating the rationale for using a large DC magnetic field overlaid with an AC field to generate optimal magnetoelectric output (B). Diagram of 
method of in vivo MENP administration. MENPs are injected bilaterally into the subthalamic region of mice, and MENPs are wirelessly stimulated using an AC and DC 
magnetic field (C). Transmission electron microscope (TEM) (D) and TEM–electron energy loss spectroscopy (TEM-EELS) images (E) show MENP morphology and BaTiO3/
CoFe2O4 phases (green and red, respectively), with quantitative elemental analysis measurement of the molar percentage of each material (E). MENPs were analyzed via 
x-ray powder diffraction (XRD) to confirm the perovskite crystal structure of BaTiO3 (green) and the spinel crystal structure of CoFe2O4 (red) (F). a.u., arbitrary units. Dy-
namic light scattering (DLS) was used to characterize MENP hydrodynamic properties in cell culture media and artificial cerebrospinal fluid (aCSF) (G). Magnetization of 
MENPs was measured over a range of −1 to 1 T, as well as oscillated over a range of 0.205 to 0.235 T (inset) (H). emu, electromagnetic unit. The input-output magnetoelec-
tric coefficient (ME) of particles in a sintered pellet was measured as a function of DC bias field in MENPs and MSNPs (I). Voltage normalized to pellet thickness of MENPs 
was measured using a 220-mT DC field while varying AC field magnitude (J). The AC field frequency dependence of ME was measured using a 220-mT DC field (K). Plots 
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with piezoelectric BaTiO3. The two materials are strain coupled via 
sol-gel growth of BaTiO3 on CoFe2O4 nanoparticles. Wireless parti-
cle stimulation is achieved by application of a magnetic field, which 
creates strain in CoFe2O4, resulting in applied strain to BaTiO3, 
thereby creating a charge separation (Fig. 1A). Below, we demon-
strate wireless generation of an electric field across MENPs using an 
applied magnetic field. We then show that magnetic stimulation of 
MENPs enables wireless modulation of neuronal activity in vitro 
and in vivo. Last, we demonstrate the therapeutic potential of this 
technology through its ability to modulate activity in the motor cor-
tex and nonmotor thalamus, and to alter animal behavior.
RESULTS
Nanoelectrodes wirelessly output electric signals via 
the magnetoelectric effect
Two-phase MENPs were synthesized using a protocol similar to 
Corral-Flores et al. (27). The nanoparticles were characterized for 
morphology (Fig. 1, D and E), magnetostrictive to piezoelectric ma-
terial ratio (Fig. 1E), and crystal structure (Fig. 1F). We observed 
two-phase MENPs containing 36.1 ± 0.6% BaTiO3 and 63.9 ± 0.6% 
CoFe2O4, in their perovskite and spinel crystal structures, respec-
tively. MENP hydrodynamic properties were also characterized via 
dynamic light scattering (DLS) in cell culture medium and an arti-
ficial cerebrospinal fluid (aCSF) solution. Average particle diameter 
was measured as 224 ± 17 nm and 277 ± 18 nm, and zeta potential 
was measured to be −8.6 ± 0.5 mV and −6.7 ± 0.5 mV, in medium 
and aCSF, respectively (Fig. 1G). Magnetization of MENPs was 
measured over a −1 to 1 T (Fig. 1H) and an oscillated 205 to 235 mT 
(Fig. 1H, inset) range.
We next measured the electrical output of MENPs under an ap-
plied magnetic field to characterize their magnetoelectric response. 
MENPs were measured as a sintered, poled pellet by attaching elec-
trodes and measuring the output voltage via a lock-in amplifier (fig. 
S1). While this method does not allow us to take measurements of 
the magnetoelectric effect at the nanoscale, it can validate whether 
our material is magnetoelectric, and has previously been used to 
evaluate magnetoelectricity in core-shell particles (28–30). A pellet 
containing only MSNPs was used as a negative control. To optimize 
our ME output, we applied a small AC magnetic field with a larger 
DC bias field along the same axis (Fig. 1B). This orientation was 
used to align the magnetic domains, axis of magnetostriction, and 
piezoelectric poling axis to sum the magnetoelectric output along 
our measured axis. Application of a sinusoidal magnetic field to 
magnetoelectric materials outputs a sinusoidal electric field with a 
frequency and duration that matches the input magnetic field. Thus, 
we could measure this output using a lock-in amplifier (29). The 
magnetoelectric coefficient (ME), which quantifies the relationship 
between the input AC magnetic field and output voltage, varied non-
linearly with the DC field, as is typical of magnetoelectric materials 
(31). The ME reached a maximum of 86 V m−1 T−1 at 200 and 225 mT 
in the MENP pellet, while the MSNP ME showed no dependence 
on the DC field (Fig. 1I). Using a DC field within the maximum ME 
range (220 mT), we measured a linear relationship between the AC 
field magnitude and the voltage (normalized to pellet thickness; 
R2 = 99.8 and 99.7% at AC frequencies of 140 and 280 Hz, respec-
tively; Fig. 1J), which is also typical of magnetoelectric materials (31).
We found a low dependence (R2 = 1.4 and 1.3% for AC magni-
tude, 2 and 3 mT, respectively) of ME on AC field frequency across 
the range tested (35 to 385 Hz), which covers the range of DBS fre-
quencies found to have clinical effect (Fig. 1K) [reviewed in (32)]. 
This frequency range also has little attenuation in tissue, thus im-
proving potential signal penetration depth (20, 21).
Magnetic stimulation of magnetoelectric nanoelectrodes 
remotely modulates neuronal cells in vitro
The effect of wireless MENP signaling on neuronal cell activity was 
examined in vitro in real time using intracellular Ca2+ signaling in 
differentiated human SH-SY5Y cells. MENPs were administered at 
100 g/ml as a suspension in the imaging medium 20 min before 
testing, using no NPs, MSNPs, and piezoelectric nanoparticles (PENPs) 
as controls. Before choosing a concentration, the toxicity of MENPs was 
assessed with a lactate dehydrogenase (LDH) assay and a metabolic 
activity assay ([3-(4,5-dimethylthiazol-2-yl)- 5-(3-carboxymethoxyphenyl)- 
2-(4-sulfophenyl)-2H-tetrazolium, MTS) (fig. S2).
Magnetic stimulation parameters were either no field, a 225-mT 
(within the maximum ME range) DC field, a 6-mT, 140-Hz AC 
field, or both DC and AC fields together using a custom coil system 
(fig. S3). The AC stimulation parameters were chosen to match fre-
quencies commonly used in clinical DBS and to maximize magneto-
electric output via an increased (6 mT) AC field magnitude. The 
DC or AC magnetic fields alone were not expected to output a mag-
netoelectric effect sufficient to modulate neuronal activity and were 
therefore used as controls.
We found a significant increase in the percentage of cells exhib-
iting Ca2+ transients when MENPs were stimulated with a simulta-
neous AC and DC magnetic field (20.1 ± 2.3%) versus basal activity 
(2.8 ± 2.6%) (Fig. 2, A to C, and movie S1). This increase was not 
observed when cells were exposed to the AC and DC magnetic stim-
ulation either alone (1.0 ± 1.7%), with MSNPs (1.4 ± 1.3%), or with 
PENPs (1.4 ± 1.2%), which supports our hypothesis that the mea-
sured increase in activity was due to the MENP response. While the 
MENPs seem to have some effect on neuronal activity (7.2 ± 5.0%, 
5.2 ± 6.0%, or 3.8 ± 5.0%, with no field, AC field only, or DC field 
only, respectively), this effect was not significantly different from 
any other negative control group (Fig. 2, B and C, table S1, and 
movie S1).
To support our hypothesis that the Ca2+ activity we measured 
was related to electrophysiological cell activity, we stimulated the 
MENPs with AC and DC magnetic fields, but first treated the cells 
with either a voltage-gated Na+ channel blocker [tetradotoxin (TTX)], 
a voltage-gated Ca2+ channel blocker (Cd2+), or an extracellular 
Ca2+ chelator (EGTA) (schematic in Fig. 2D showing drug activity). 
In the presence of each drug, the cells failed to produce any Ca2+ 
transients (Fig. 2, D and E).
Nanoelectrodes in the mouse deep brain wirelessly 
modulate local brain activity
We then sought to assess the feasibility of MENP-based neuromod-
ulation in vivo. MENPs were bilaterally injected into the subtha-
lamic region of naïve mice (C57Bl/6J) at a dose of 100 g per animal 
(1 l total at 100 mg/ml), which was found to be tolerable in a dose 
toxicity assessment (fig. S4). We found no significant difference in 
glial fibrillary acidic protein (GFAP) or Iba-1 staining surrounding 
the injection site using an MENP concentration of 25, 50, or 100 mg/ml 
(fig. S4, C and D). We also evaluated the injection site at 48 hours, 
2, and 4 weeks following injection of MENPs at 100 mg/ml and saw 
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Animals euthanized at 7 weeks postinjection during phase 3 of our an-
imal studies also showed no qualitative signs of MENP migration or loss. 
We analyzed the region of injection in these mice postmortem and found 
that the MENPs occupied a volume of 0.0088 ± 0.0023 mm3 (Fig. 3D).
During magnetic stimulation, mice were awake and unrestrained 
within our in vivo magnetic coil device (fig. S5). As a control group, 
mice were treated with MENPs and a DC magnetic field only, 
meaning that they were placed into the magnetic device but with the 
AC coil remaining off. We assessed changes in local neural activity 
by immunohistochemically measuring the expression of c-Fos pro-
tein, a widely used cell activity marker (33). We found significantly 
more c-Fos–positive cells in the region of nanoparticle injection 
when animals were treated with MENPs and an AC and DC field 
(38.5 ± 8.0 cells) versus only a DC field (4.25 ± 3.0 cells) (Fig. 3, 
A to C). Furthermore, the volume of tissue containing c-Fos–positive 
tissue was significantly larger (0.0349 ± 0.0089 mm3) when animals 
were treated with MENPs and an AC and DC field versus only a DC 
field (0.0098 ± 0.0031 mm3). The region of tissue containing MENPs 
was not significantly different (0.0090 ± 0.0014 and 0.0085 ± 
0.0031 mm3, respectively) (Fig. 3D).
DBS via nanoelectrodes modulates basal ganglia circuitry 
and alters mouse behavior
We next wanted to determine whether local subthalamic neuro-
modulation induced by MENPs was sufficient to cause modulation 
in other regions of the cortico-basal ganglia-thalamocortical circuit. 
Fig. 2. Magnetic stimulation of MENPs modulates neuronal cell activity in vitro. Cells were treated with MENPs, using no NPs, MSNPs, or PENPs as controls, before 
magnetic stimulation. Magnetic stimulation was 220 mT DC (DC), 6 mT and 140 Hz AC (AC), or both DC and AC fields along the same axis (AC + DC). Neuronal activity was 
measured in real time via intracellular Ca2+ imaging using Fluo4 dye, and cell fluorescence was traced over time per cell. Images of total Ca2+ activity over time is shown 
for selected experimental groups. Calibration bars represent F/Fo (A). The percent of cells demonstrating intracellular Ca2+ transients in (A) is summarized in (B), and 
significantly different group comparisons are marked in yellow within (C). Cells were treated with TTX, Cd2+, or EGTA before treatment with MENPs and AC and DC mag-
netic stimulation, and total Ca2+ activity over time is shown next to a diagram depicting the inhibiting activity of each drug (D). Measured Ca2+ transients of drug-treated 
cells are summarized with no drug, MENP, and AC + DC field–treated cells shown as faded plot points for comparison (E). Plots show traces of Ca2+ activity over time in 
individual cells (A and D) and individual points with bars showing means ± SD (B and E) (n = 3 to 6); ANOVA with Tukey’s posttest (C) or Dunnett’s posttest with no drug as 
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We found c-Fos protein expression significantly higher in the motor 
cortex and nonmotor thalamus following stimulation with MENPs 
and an AC/DC magnetic field (1046.4 ± 232.4 and 348.4 ± 137.7 cells/
mm2, respectively) versus only a DC magnetic field (424.8 ± 214.9 
and 19.9 ± 27.6 cells/mm2, respectively) (Fig. 3, E to H). We did not 
observe a global change in c-Fos protein expression, such as in the 
CA1 region of the hippocampus (Fig. 3, G and H).
To determine whether the induced neuromodulation would af-
fect animal behavior, we tested mice via a rotarod test and the auto-
mated CatWalk XT gait analysis system. Mice were injected with 
MENPs or MSNPs as a control. Behavior with AC and DC magnetic 
stimulation versus behavior with only DC magnetic stimulation 
was compared for each mouse. Gait- and balance-related static pa-
rameters during the CatWalk test, such as regularity index, run 
maximum variation, and base of support, showed no significant dif-
ference following AC and DC stimulation in either nanoparticle 
group (MSNPs: 97.3 ± 2.5 versus 97.9 ± 1.8%, 28.3 ± 7.6 versus 
31.9 ± 11.0%, and 1.2 ± 0.1 versus 1.2 ± 0.1 cm, DC versus AC and 
DC stimulation, respectively) (MENPs: 97.8 ± 1.0 versus 98.1 ± 1.3%, 
23.7 ± 3.3 versus 23.6 ± 8.9%, and 1.2 ± 0.1 versus 1.2 ± 0.1 cm, DC 
versus AC and DC stimulation, respectively) (Fig. 3, J and K, and 
movie S2). Rotarod testing also showed no significant difference in 
latency to fall with either nanoparticle group (MSNPs: 170.4 ± 72.9 
versus 170.9 ± 73.2 s; MENPs: 202.6 ± 40.4 versus 184.0 ± 40.5 s, DC 
versus AC and DC stimulation) (Fig. 3K). Overall, no significant 
difference in measured gait and balance parameters was found be-
tween the groups. This was important to establish that magnetic 









Fig. 3. Magnetic stimulation of MENPs locally modulates neural activity in mice, yielding modulation of basal ganglia circuitry and behavioral change. Staining 
for c-Fos protein locally to the MENP injection site following DC magnetic stimulation (A) or AC and DC magnetic stimulation (B) shows increased c-Fos expression (C) and 
increased c-Fos–positive tissue volume (D) in the latter. Quantification of c-Fos expression in the motor cortex (E) and limbic thalamus (F) shows increased expression 
when MENPs were stimulated with an AC and DC magnetic field (H) versus only a DC magnetic field (G). TH, Thalamus; cp, Cerebral Peduncle; STh, Subthalamic nucleus, 
HPF; Hippocampal formation; cc, corpus callosum; PV, paraventricular nucleus. Time-lapse images showing mouse movement in a CatWalk video recording system 
(I). Dynamic movement parameters as measured by the CatWalk recording showed significant changes in mouse speed, limb duty cycle, and limb stride length (J) in 
MENP-treated mice following AC and DC stimulation versus DC stimulation, while MSNP-treated mice showed no significant change. Static movement parameters of 
mouse movement such as regularity index, run maximum variation, and front-paw base of support as measured by CatWalk recording did not significantly change with 
AC and DC versus DC only magnetic stimulation in either nanoparticle group (K). Rotarod latency to fall also did not significantly change with AC and DC versus DC only 
magnetic stimulation in either nanoparticle group (K). Scale bar, 250 (overview) and 50 m (inset) (A, B, G, and H). Plots show individual points with bars showing 
means ± SD (C to F, J, and K) [n = 8 mice (C); n = 6 to 7 mice (D to F); n = 8 to 9 mice (J and K), individual limb values for duty cycle and stride length]; unpaired t test (C to F) or 
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Conversely, in analyzing the speed-related and dynamic param-
eters of the CatWalk test, which are indicative of high-speed gait, we 
found a significant difference in the behavior of MENP-treated an-
imals that was not observed in MSNP-treated animals (Fig. 3, 
J and K, and movie S2). The average speed, duty cycle of each limb, 
and stride length of each limb all changed significantly in MENP- 
treated mice following AC and DC stimulation (51.1 ± 10.9 versus 
33.6 ± 4.8 cm/s, 48.1 ± 3.0 versus 49.9 ± 3.5%, and 8.1 ± 0.5 versus 
7.3 ± 0.7 cm, DC versus AC and DC stimulation, respectively) but 
not in MSNP-treated mice (28.3 ± 5.0 versus 29.4 ± 3.8 cm/s, 
51.9 ± 3.9 versus 51.1 ± 3.2%, and 6.5 ± 0.4 versus 6.4 ± 0.6 cm, DC 
versus AC and DC stimulation, respectively).
DISCUSSION
As the potential applications of neural devices have increased, new 
technologies to make neural intervention safer, longer-lasting, and 
less invasive have generated interest in smaller and wireless devices. 
Remote powering of neural devices not only allows for smaller de-
vice sizes but can also eliminate the need for bulky equipment or 
surgical battery changes. Recently, several remotely powered devices 
have emerged that could enable less invasive neuromodulation, 
with some even reaching deep brain sites (3, 12–18). The most clin-
ically promising of these do not rely on transgenesis of neural tissue 
but instead directly create electric signals to achieve neuromodula-
tion (12–14, 17, 18). However, it has not yet been possible to scale 
down such devices sufficiently to enable complete implantation in 
the brain while still achieving deep brain neuromodulation.
In this work, we used MENPs as nanoelectrodes, with the goal 
of wirelessly modulating neuronal activity using remote powering 
via a magnetic field. We characterized the magnetization of the 
MENPs, particularly looking at a field range oscillated over the 
range of fields used during in vitro and in vivo experiments, and 
found no magnetic hysteresis (Fig. 1H, inset). This is important to 
show that the MENPs would not produce heat during in vitro and 
in vivo experiments, thus eliminating heat as a source of off-target 
neuromodulation.
We characterized the magnetoelectric response of the nanoelec-
trodes as a sintered pellet, particularly looking at electrical output as 
input magnetic field changed. While a magnetoelectric response 
can be initiated with just an AC magnetic field, large AC fields are 
required to approach the maximum ME, which would require power-
ful coil systems and additional components to enable active cooling. 
Instead, we applied a large DC magnetic field using permanent 
magnets and overlaid a smaller AC field to maximize ME (Fig. 1, 
B and C, and figs. S3 and S5). While varying each input component 
(i.e., DC field magnitude, AC field magnitude, and AC field fre-
quency), we determined that the MENP nanoelectrodes output an 
electric response characteristic of magnetoelectric materials (Fig. 1, 
I and J). We did not find this behavior using magnetic only, MSNPs.
An important finding in this study that corresponds with previ-
ous work in magnetoelectric materials is that the magnetoelectric 
output had a low dependence on the input, carrier AC field fre-
quency (Fig. 1K). While ME increases sharply near the mechanical 
resonance frequency of magnetoelectric materials, ME otherwise 
remains relatively constant (34). In this study, our carrier magnetic 
signals were far from the resonant frequency range of nanoscale 
materials (140 Hz versus GHz range). Previous neural device tech-
nologies based on piezoelectric and magnetoelectric materials have 
often relied on carrier frequencies that provide resonant coupling 
for remote powering (12, 13, 18). However, this fundamentally cre-
ates an inverse correlation between device sizes as compared to car-
rier frequency and possible tissue penetration depth. As a result, such 
devices have been unable to demonstrate neuronal modulation in 
deep brain tissue using injectable-sized devices.
As resonant coupling–independent signaling to magnetoelectric 
materials yields a lower ME, we next needed to determine whether 
signaling to MENPs away from resonance would yield sufficient 
output electric signaling to modulate neuronal activity. Resonant 
coupling to magnetoelectric materials has been shown to generate 
electric fields much higher than the necessary threshold for neuro-
modulation (18). We therefore hypothesized that using magneto-
electric materials and resonant coupling–independent signaling, we 
would be able to modulate brain activity using nanoscale materials.
We first assessed this in neuronal cells in vitro, measuring intra-
cellular Ca2+ as a second messenger of electrophysiological activity. 
As we showed earlier that both the large DC and small AC magnetic 
fields were necessary to generate a magnetoelectric output (Fig. 1, 
I and J), we used the AC and DC fields individually as controls for 
potential side effects caused by the magnetic fields alone. We also 
used PENPs and MSNPs as material controls, as neither piezoelec-
tric nor magnetostrictive materials alone generate an electric output 
to a magnetic input, so any cell activity increases with these materi-
als would signal modulation due to extraneous effects. Cells in all 
control combinations tested showed no significant difference in the 
percent of cells displaying Ca2+ transients, while AC and DC mag-
netic stimulation of MENPs significantly increased cells with tran-
sients versus all other controls (Fig. 2, A to C).
To support our hypothesis that the measured Ca2+ transients 
were due to the electrophysiological activity of the cells, we treated 
cells with drugs to independently block the activity of voltage-gated 
Na+ channels, voltage-gated Ca2+ channels, or extracellular Ca2+ 
sources. With the application of these drugs, magnetic stimulation 
of MENPs showed significantly lower neuronal Ca2+ activity versus 
stimulation without blocking drugs (Fig. 2, D and E). This substan-
tiates the dependence of our measured Ca2+ transients on voltage- 
gated ion channels and extracellular Ca2+ sources, supporting the 
relationship between our measured Ca2+ activity and cell electro-
physiological activity.
Next, an in vivo study was conducted to assess the feasibility of 
MENP-based DBS. To this aim, naïve mice received bilateral injec-
tion of MENPs in their subthalamic region. The injected MENPs 
were stimulated using an AC and DC magnetic field, with a DC 
field only serving as a control. The rationale behind region selection 
was that the basal ganglia and the subthalamic region are common 
target areas for DBS (35). Moreover, these areas have been thor-
oughly studied with regard to brain circuits in the field of DBS and 
neuromodulation for neurological disorders (36, 37). These struc-
tures are connected to higher (cortical via thalamus) and lower 
(brainstem) areas through both partially parallel and partly inte-
grated projections. These projections are primarily responsible for 
motor control, as well as other functions such as motor learning, 
associative functions, and emotions. According to the classical basal 
ganglia model, information flows through the basal ganglia back to 
the cortex through two pathways, while new models show that par-
allel circuits subserve the classical functions of the basal ganglia, 
engaging associative and limbic territories (38, 39). Therefore, the 
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to reliably investigate the effects of neuromodulation on a wide 
range of behavioral functions.
MENPs were implanted using stereotactic injection into the sub-
thalamic region. Using a dose of 100 g per animal, we determined 
that the MENPs occupied a volume comparable to a conventional 
rodent DBS electrode (0.3 mm in diameter). As both a conventional 
DBS electrode and the MENPs could displace tissue upon implanta-
tion, this coverage area could control for a potential sham effect. A 
dose toxicity assessment of tissue following MENP injection at dif-
ferent concentrations led us to confirm this concentration, as it 
showed no significant change in inflammatory markers versus other 
concentrations tested (fig. S4, C and D). A qualitative evaluation of 
this particle dosage showed no change in the volume of MENPs or 
the tissue response to the MENPs over a 4-week period. The injected 
MENPs were also still present at the site of injection 7 weeks postin-
jection (Fig. 3A).
We evaluated local neuronal activity in the region of MENP in-
jection using an antibody against c-Fos, a widely used cell activity 
marker (33). Quantification of stained sections showed a signifi-
cantly higher number of c-Fos–positive cells in the region of MENP 
injection in animals treated with AC and DC fields versus only a DC 
field (Fig. 3, A to C). We also found a significantly larger volume of 
tissue containing c-Fos–positive cells surrounding MENPs stimu-
lated with an AC and DC magnetic field versus only a DC field 
(Fig. 3D). These data support our hypothesis that we could wirelessly 
modulate local brain activity using the magnetoelectric response of 
MENPs to magnetic stimulation.
To determine whether the local neuronal activity induced by MENPs 
was sufficient to drive neuronal activity in thalamocortical pathways, 
we assessed c-Fos protein expression in other regions of the brain. 
We found that c-Fos protein expression is significantly higher in the 
motor cortex and paraventricular nucleus (PV) of the thalamus follow-
ing stimulation with MENPs and an AC/DC magnetic field versus only 
a DC magnetic field (Fig. 3, E to H). We observed a selective, not 
global, c-Fos protein expression in the brain of stimulated animals. 
Together, these data support our hypothesis that the measured increases 
in c-Fos protein expression were due to local subthalamic stimula-
tion of the cortico-basal ganglia-thalamocortical circuit and not a non-
specific, global modulation of neural activity via the magnetic field.
Next, we tested the mice in a rotarod test and the automated 
CatWalk gait analysis system to determine whether the induced 
neuronal modulation in thalamocortical pathways would affect an-
imal locomotion. Gait- and balance-related static parameters during 
the CatWalk test, which measure motor function, showed no signif-
icant difference following AC and DC stimulation in either nano-
particle group (Fig. 3, I to K). Rotarod testing also showed no significant 
difference in latency to fall with either nanoparticle group (Fig. 3K). 
While we anticipated no improvement in motor function, as we 
tested only naïve mice, these results are important to demonstrate 
that we saw no detrimental effect to the gait and balance of the 
animals due to neuromodulation via MENPs. This finding of no 
generalized behavioral change also corresponds to our c-Fos expres-
sion findings, in which we found only selective expression changes.
When analyzing the dynamic parameters of the CatWalk test, 
which are indicative of animal speed, we found a significant change 
in the behavioral parameters of MENP-treated animals, but not 
MSNP-treated animals (Fig. 3, I to K). Specifically, we saw an in-
crease in speed, which concomitantly lead to an increase in stride 
length, and a decrease in duty cycle (i.e., a decrease in the percent-
age of each stride spent in stance versus swing). The aforementioned 
selective behavioral responses are intriguingly in line with selective 
c-Fos expression in the PV. Current literature presents ample evi-
dence that the PV relays information projected from the brainstem 
and subthalamic areas to the nucleus accumbens and the amygdala, 
as well as the cortical areas associated with these subcortical regions 
(40). Selective activation of the PV is known to produce states of 
arousal that contribute to fear, anxiety, reward regulation, and de-
fensive behavior (40). Expression of different gaits is adapted to be-
havioral demands during locomotion. In this regard, alternating 
gaits like walking and exploration take place at slower locomotor 
speeds, while synchronous gaits during escape are present at fast 
locomotor speeds (41). Although the exact neuronal substrate(s) 
behind them have not yet been elucidated, recent evidence suggests 
that low- and high-speed gaits arise from distinct midbrain areas 
(42). Given that the static versus dynamic CatWalk gait parameters 
are more likely to be affected during low- versus high-speed loco-
motion, respectively, it is conceivable that dynamic gait parameters 
are mainly altered because of increased running speed in this study.
On the basis of this evidence, we believe that the measured 
changes in animal speed are due to wireless subthalamic stimula-
tion via MENPs. The combined results of c-Fos protein immuno-
histochemistry and animal behavioral tests support the conclusion 
that magnetically stimulated MENPs wirelessly modulated neurons 
within deep brain sites to affect brain behavior. On the basis of these 
data, we suggest that the MENPs were able to evoke specific behav-
ioral changes correlated with selective perturbation in the thalamo-
cortical circuit.
While we found changes in animal behavior linked to anxiety, in 
the future, it will be important to assess the therapeutic effect of 
wireless modulation in animal disease models. Healthy animals 
would not be expected to show a benefit in motor function with 
successful DBS. Therefore, in this study, we could only assess ani-
mal locomotion to determine that we did not detrimentally affect 
movement. Studying DBS via magnetoelectric nanoelectrodes in a 
Parkinsonian model will, in the future, be necessary to measure a 
benefit to motor function.
A key finding of this work is that resonant coupling–independent 
remote powering of a neural device yields sufficient electrical activ-
ity to modulate brain activity. This decouples the relationship be-
tween device size and potential powering depth, enabling nanoscale 
materials to modulate deep brain tissue. Modeling of carrier signal 
transmission through tissue to magnetoelectric devices would ben-
efit future device design and elucidate limitations on tissue penetra-
tion to human-scale deep brain targets. Furthermore, future work 
will be necessary to understand how the carrier frequency is propa-
gated by the MENPs into a stimulating signal that is received by 
neurons, as temporal control of stimulation is the key to the thera-
peutic effects of DBS (43, 44). The exact mechanism of neuronal 
modulation also remains an open question. Hence, future work will 
be necessary to learn more about the various input parameters (e.g., 
nanoparticle concentration, magnetic stimulation magnitude, stim-
ulation frequency, and duration) that enable modulation. As the 
electric field gradient along an axon has been shown to be a key 
determinant in activation (45, 46), we hypothesize that the mecha-
nism of action may be related to high gradients generated along the 
very small nanoparticles. However, field gradients at the nanoscale 
have never been evaluated in relation to neuronal activation. 
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response at the nanoscale, as well as how the MENPs and their fields 
interact, to speculate further. With regard to the longevity of the 
MENPs, while we know that they remain at the injection site and 
modulate neurons as long as 7 weeks postinjection, translation of 
this technology to patients would require a further study of the 
long-term compatibility, immune response, and functionality of the 
nanoparticles. However, this work represents an important proof of 
concept in remote powering of nanoscale neural devices.
The results herein demonstrate the potential of magnetoelectric 
materials as nanoelectrodes for wireless electrical modulation of 
deep brain targets. We have shown that we can stimulate MENPs 
with a magnetic field to remotely generate electric polarization of 
the MENPs. We have shown evidence that nonresonant magnetic 
powering of MENPs locally modulates neuronal activity in vitro 
and in vivo. We have also demonstrated that this modulation is suf-
ficient to change animal behavior and to modulate other regions of 
the corticobasal ganglia-thalamocortical circuit. Future work will 
be the key to optimizing magnetoelectricity-based neural devices 
and understanding the abilities and limitations of this technology. 
Magnetoelectric nanoelectrodes show promise for new technologies 
in wireless neural devices.
MATERIALS AND METHODS
Study design
The objective of this study was to assess the potential of MENPs to 
wirelessly modulate neuronal activity via a magnetoelectric re-
sponse to an applied magnetic field. This was approached by apply-
ing a magnetic field to the MENPs (and control nanoparticles) and 
measuring (i) their output electric signaling, (ii) their ability to 
modulate neuronal cell activity in culture, (iii) their ability to mod-
ulate brain activity in mice, and (iv) the effect of this modulation on 
mouse behavior. While an ongoing and measurable magnetoelec-
tric effect was expected only when applying a large DC magnetic 
field overlaid with a smaller AC magnetic field, AC and DC mag-
netic field application alone were used as experimental controls. All 
experiments in this study were carried out via controlled laboratory 
experiments. Sample sizes were determined independently for each 
experiment without formal power analysis. Where appropriate, ref-
erences used to determine sample size are cited. Sample size is listed 
in the methods of each experiment, as well as in the figure captions 
where results are shown. The methods below also include a description 
of how sample size corresponds to sampling versus experimental 
replicates. Endpoints varied by experiment and are listed below. Ex-
clusion criteria for animal safety are listed below in the description 
of the toxicity analysis. However, no animals were excluded from 
the study due to these criteria. Animal behavioral testing was done with 
the experimenter and data analyst blind to animal identity. Informa-
tion regarding cell line, animals, and antibodies used is listed below. 
Ethical oversight and approval of animal studies are listed below.
MENP synthesis
MENPs were synthesized in a manner similar to Corral-Flores et al. 
(27). CoFe2O4 nanoparticles (30 nm; Sigma-Aldrich) were suspended 
in deionized water (dH2O) at a concentration of 10 mg/ml to 80°C 
while stirring. Oleic acid was added to the suspension at 30 weight 
% with respect to CoFe2O4, the temperature was raised to 90°C for 
30 min and then lowered to 60°C. Octane was added to the suspension 
at a 1:1 ratio to the dH2O volume, which separated oleic acid–coated 
CoFe2O4 particles into the organic layer. The organic layer was then 
washed with dH2O three times. Barium acetate and titanium butoxide 
were dissolved in glacial acetic acid with stearic acid (final concen-
tration, 0.01%) such that the final molar ratio of BaTiO3 to CoFe2O4 
was 1:3. This solution was stirred and heated to 90°C, the CoFe2O4 
solution was added, as well as 2-methoxyethanol, at a final volume 
concentration of 30%. The solution was dried, calcined at 700°C for 
2 hours, and then ground with a mortar and pestle. MSNP control 
particles were the unmodified, commercially available CoFe2O4 
nanoparticles used as the MENP core. PENP control particles were 
commercially available BaTiO3 nanoparticles (50 nm; Sigma-Aldrich). 
To select for particles with better colloidal stability, all nanoparticles 
were suspended in dH2O and centrifuged for 1 min at 10g, and par-
ticles within the supernatant were kept for further experiments.
X-ray diffraction analysis of MENP crystal structure
X-ray diffraction (XRD) analysis of MENPs was carried out on a Bruker 
D8 Advance Powder Diffractometer using Cu radiation generated 
at 40 kV/40 mA with a Bragg-Brentano beam path. A divergence slit 
at 0.5°, antiscatter slits at 2° and 4°, and Soller slits were used. The 
output beams were received using a VÅNTEC-1 one-dimensional 
(1D) detector. Peaks were identified using the International Centre 
for Diffraction Data database. MathWorks MATLAB software was 
used to baseline-correct the spectrum, using the msbackadj function.
Elemental analysis of MENPs to determine  
chemical composition
MENP elemental analysis was carried out via inductively coupled 
plasma (ICP)–optical emission spectrometry using a Spectro Ciros 
spectrometer (Kleve, Germany). MENPs were first dissolved in an 
aqueous solution of 3% HNO3 and 1% HF before sample loading in 
the spectrometer. Data were analyzed using Spectro ICP Analyzer 
software to detect Ba, Ti, Co, and Fe spectra. Data are presented as the 
means ± SD of each element measured within BaTiO3 and CoFe2O4.
Transmission electron microscopy and electron energy loss 
spectroscopy analysis of MENP morphology
MENPs were prepared for transmission electron microscopy (TEM) 
analysis by drop-casting an aqueous suspension onto C-coated Cu 
TEM grids and air-drying. TEM and TEM–electron energy loss spec-
troscopy (EELS) images were acquired using a Zeiss Sub-Electron-
volt Sub-Angstrom Microscope. Data were acquired in TEM mode 
at 200 kV. For EELS, we acquired energy-filtered TEM spectrum 
images from 30 to 120 eV, with 3-eV steps and 4× binning. After 
data acquisition, the EELS signal from Ba (N4,5 edge, 90 eV) and Fe 
(M2,3 edge, 54 eV) was extracted and used for the elemental map.
Analysis of MENP hydrodynamic properties
Hydrodynamic diameter and zeta potential of MENPs were mea-
sured via DLS using a Wyatt Mobius DLS Instrument and analyzed 
via Wyatt DYNAMICS software. MENPs were diluted to a concen-
tration of 100 g/ml in either our cell culture differentiation media 
(see below) or an aCSF solution (47) during the measurements. 
Data were analyzed from three independent experiments.
Analysis of MENP magnetic properties
A Microsense EZ vibrating sample magnetometer (VSM) was used 
to measure the magnetic properties of MENPs. MENPs were measured 
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wax. Magnetization was measured over a range of −1 to 1 T, as well 
as oscillated over a range of 205 to 235 mT.
Formation of sintered pellets of nanoparticles  
and pellet wiring
For ME measurement of pellets, 0.65 g of MENPs were mechanical-
ly pressed into a pellet of diameter of 8 mm using 6 tonnes/cm2 of 
pressure and then sintered at 1150°C for 12 hours. MSNP pellets 
were prepared in the same way but using only CoFe2O4 nanoparti-
cles. The circular surfaces of the pellets were painted with conduc-
tive silver glue to attach copper plates (fig. S1A). Pellets were heated 
to 140°C, electrically poled at thickness of 1 kV/mm for 5 min, and 
then allowed to cool to room temperature while maintaining the 
applied voltage. The pellets were then wired to a charge amplifier. 
The pellet and charge amplifier were enclosed in a Faraday shield 
and connected externally to a lock-in amplifier for voltage measure-
ment (fig. S1, B to H).
Charge amplifier design
For electrical measurement of the magnetoelectric response of pel-
lets, a charge amplifier is used to eliminate the effects of stray ca-
pacitance on the measurement of the piezoelectric charge. The 
battery-powered amplifier was constructed on a standard FR4 
printed circuit board, which was placed within the Faraday shield. 
The charge amplifier uses an operational amplifier circuit (fig. S1, F 
to H) based on the Texas Instruments OPA340. The amplifier has a 
high-pass characteristic with a −3 − dB frequency of 3 Hz, and the 
calculated gain of the circuit in the passband is 200 mV/pC.
Magnetoelectricity measurements
A Microsense EZ VSM was used as a DC magnetic field source and 
was modified to hold an additional, smaller Helmholtz coil. This 
was powered with a signal generator (35- to 385-Hz sine wave) con-
nected to a linear voltage amplifier (Hewlett Packard) to provide cur-
rent to the smaller coils, generating an AC magnetic field in the plane 
of the sample. The pellet was oriented such that the AC and DC mag-
netic fields were parallel to the pellet’s central axis (fig. S1E). The AC 
magnetic field magnitude was measured using a gaussmeter before 
experimentation. Pellets were demagnetized before all measurements.
Culture and differentiation of SH-SY5Y neuronal cells
SH-SY5Y cells were purchased from the Deutsche Sammlung von 
Mikroorganismen und Zellkulturen (DSMZ) (American Type Cul-
ture Collection CRL-2266). Maintenance cultures were grown in 
Dulbecco’s modified Eagle’s medium (DMEM)/F12 (Gibco) with 10% 
fetal bovine serum (FBS) and 1% penicillin/streptomycin, at 37°C with 
5.0% CO2. Media was changed every 3 to 4 days. Before plating for 
experiments, wells were coated with laminin (5 g/ml) in phosphate- 
buffered saline (PBS) with Ca2+/Mg2+ for 1 hour at 37°C. For Ca2+ sig-
naling experiments, cells were plated at a concentration of 20,000/cm2 
onto cell culture–treated, four-well IBIDI -slides. For toxicity analysis, 
cells were plated at a concentration of 20,000/cm2 onto cell culture–
treated 96-well plates. Experimental cultures were differentiated in 
DMEM/F12 medium containing 1% FBS, 1% penicillin/streptomycin, 
and 10 M retinoic acid (Sigma-Aldrich) for 4 days before all experiments.
Analysis of cell toxicity
MENPs were suspended in experimental cell culture medium at a 
concentration of 0, 50, 100, 200, or 300 g/ml and added to cells. 
Toxicity was assessed at 24 hours following MENP administration 
via a CyQUANT LDH assay kit (Thermo Fisher Scientific), as well 
as a CellTiter 96 AQueous One MTS assay. Assay results were read 
using a BioTek Synergy 2 Microplate Reader (fig. S2). Each experi-
ment was tested within four wells, and the average of these values 
was recorded to provide a single data point. The data were analyzed 
from three independent experiments.
In vitro magnetic stimulation
A magnetic stimulation setup was designed to fit into a Zeiss Axio 
Observer A1 microscope and to hold a four-well IBIDI -slide (fig. 
S3). A DC magnetic field was provided by three permanent NdFeB 
magnets (N42, 6 cm in diameter, 5 mm in height; Supermagnete) on 
either side of the cells to generate a 225-mT field at the center of the 
cell culture well. A magnetic coil was used to provide an AC magnetic 
field along the same axis. AC signals were generated by a National 
Instruments DAQ USB X-Series device, controlled via LabVIEW 
software, and amplified by a class D audio amplifier. For all experi-
ments with AC magnetic stimulation, the AC field component was 
a 6-mT sine wave at 140 Hz applied during the time window of 
10 to 30 s during the time-lapse recording. AC and DC magnetic 
field magnitudes were verified with a magnetometer.
Ca2+ signaling experiments
Cells were loaded with 1 M Fluo4-AM dye (Thermo Fisher Scien-
tific) in Live Cell Imaging Solution (LCIS; Invitrogen) for 30 min at 
37°C. Experimental suspensions of no NPs, MENPs, PENPs, or 
MSNPs were prepared at 100 g/ml in LCIS. After Fluo4 loading, 
cells were washed three times with LCIS, and particle suspension 
solutions were added. Cells with particles were incubated for 20 min 
at 37°C to allow Fluo4 to deesterify and then moved onto a Zeiss 
Axio Observer A1 microscope mounted with the in vitro coil sys-
tem. For experiments using inhibitory drugs, Fluo4 loading was 
carried out as described above, and drugs were added in the LCIS 
with MENPs after washing. For EGTA, PBS was used instead of 
LCIS and was added during the Fluo4 loading step. TTX was added 
at a concentration of 100 nM, CdCl2 (Cd2+) was added at 100 M, 
and EGTA at 5 mM, which have previously been determined to be 
inhibitory but nontoxic concentrations (14).
Fluo4 was excited using a 470-nm LED with a 484/25-nm exci-
tation filter and observed through a 519/30-nm emission filter. Time- 
lapse images were taken at ×10 magnification, every 1 s for 240 s 
using 50-ms illumination and recorded using a Zeiss Axiocam 503 
mono camera (2.8 megapixels). Data were collected from three to 
six independent experiments per group.
Time-lapse recordings were analyzed using ImageJ software. 
Briefly, the first 10 images of each time lapse were stacked into a 
single image to enable region of interest (ROI) selection. Following 
brightness normalization, blurring, background subtraction, and 
thresholding, ROIs were selected from this image using the Analyze 
Particles function (with all settings remaining consistent for all time 
lapses). These ROIs were then overlaid onto the completely unmod-
ified time-lapse series, and the mean gray value within each ROI 
was recorded for each frame. These values were then used to calcu-
late Ca2+ transient amplitudes as F/Fo. Cells positively showing 
Ca2+ transients were calculated using MathWorks MATLAB soft-
ware, using a linear baseline correction and the peakfinder function. 
Images in Fig. 2 (A and D) were generated by creating a maximum 
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Animals
Experiments were performed on 65 male naïve mice (C57Bl/6J; 
the Jackson Laboratory). Mice were socially housed under con-
trolled conditions (21° ± 2°C and 40 to 60% humidity) in a reversed 
12-hour day/night cycle (lights on, 7 p.m.) until they had received 
surgery. Mice were given ad libitum access to food and water. At the 
time of surgery, mice were 3 months of age. Experiments were con-
ducted according to the directive 2010/63/EU for animal experiments 
and in agreement with the Animal Experiments and Ethics Commit-
tee of the Maastricht University, Maastricht, The Netherlands.
Stereotactic nanoparticle administration
Buprenorphine (0.1 mg/kg) was subcutaneously injected half an hour 
before surgery as an analgesic. Inhalational anesthesia was induced 
and maintained with isoflurane (Abbot Laboratories, Maidenhead, 
UK) at 4% and 1.5 to 3%, respectively. After adequate induction of 
the anesthesia, the mouse was placed in a small animal stereotaxic 
frame (Stoelting, Dublin, Ireland) and fixed by ear bars with zygoma 
ear cups (Kopf, Los Angeles, USA) and a mouse gas anesthesia 
head holder (Stoelting, Dublin, Ireland). To maintain body tem-
perature at 37°C throughout the whole procedure, the mouse was 
placed on a thermoregulator pad. An ocular lubricant was applied to 
prevent drying of the eyes. A subcutaneous injection of 1% Lidocaine 
(Streuli Pharma, Uznach, Switzerland) at the incision side was given 
for local anesthesia.
Consecutively, burr holes above the subthalamic area [anterior- 
posterior (AP): −2.06 mm, medial-lateral (ML): ±1.50  mm, dorsal- 
ventral (DV): −4.50] were made, and a total of 2 l of MENPs or 
MSNPs was injected with a microinjection apparatus Nanoject II 
(Drummond Scientific). The infusion rate was 100 nl/min. After the 
injections, the syringe needle remained inside the brain for another 
10 min before a slow withdrawal.
In vivo magnetic stimulation
All in vivo magnetic stimulation was carried out using a custom 
coil system that would allow mice to move freely during the exper-
iments. The animal experiment setup was designed to provide a 
220-mT DC magnetic field with a 6 mT, 140-Hz AC magnetic 
field along the same axis at the center of the animal chamber. Im-
ages and the design of the in vivo coil system are shown in fig. S5. 
The structure was 3D-printed with Acrylonitrile Butadiene Styrene 
using a uPrint SE Plus 3D printer. A DC magnetic field was pro-
vided by six NdFeB disk magnets (N42, 6 cm in diameter, 5 mm 
in height; Supermagnete) on each side of the animal chamber. As 
safety precautions, the permanent magnets were covered with a 
protective lid, and the animal holder base was 3D-printed using 
the solid option for higher durability. The AC magnetic field was 
provided by two coils on either side of the animal chamber. A 
1-mm-thick copper wire was wound around a 3D-printed plastic 
coil frame with 360 turns each. Corresponding coil-pair resistance 
was 4.94 ohm, and coil-pair inductance was 24.5 mH. A Voltcraft 
8210 signal generator was used to provide a 140-Hz sine wave, 
which was amplified using a QSC-GX7 power amplifier. These 
were then connected to the AC coils. AC and DC magnetic field 
magnitudes were verified with a magnetometer. For all AC and 
DC stimulation experiments, mice were stimulated with the coil 
turned on for 180 s. For DC only stimulation experiments, mice 
were placed into the animal chamber for 180 s with the coil re-
maining off.
Description and timelines of animal experimental procedures
Phase I: Toxicity assessment
We first adjusted optimal concentration of MENPs. Three doses 
were tested, including 25, 50, and 100 mg/ml. Mice were randomly 
assigned to either 25, 50, or 100 mg/ml test groups (n = 8) and re-
ceived stereotactic injection of MENPs (fig. S4A). Animals were 
monitored for signs of sub- or epidural hemorrhage, neurological 
symptoms of the injection, welfare (weight, responsiveness, and wa-
ter intake), and discomfort/pain. No animals were eliminated from 
the experiments due to failing these criteria. Fourteen days after the 
surgery, mice were euthanized for immunohistochemical (IHC) 
analysis of the brain as described below. Five brains were randomly 
selected for IHC. Sections belonging to one mouse were excluded as 
tissue ruptured during processing. Brain sections were processed 
using antibodies raised against astrocytes and microglia (fig. S4, B 
and C). Another series of brain sections were stained using standard 
hematoxylin and eosin (H&E) to evaluate tissue damage at the site 
of injection (fig. S4D).
Phase II: Persistence of nanoparticles at injection site and c-Fos 
protein expression
Mice were randomly assigned to three test groups (n = 8) and re-
ceived stereotactic injection of MENPs (100 mg/ml). We tested the 
washout of MENPs at different time points including 48 hours, 2, 
and 4 weeks (fig. S4, E and F). At the end of each time point, mice 
underwent transcardial perfusion, and brains were removed and 
used for IHC and H&E analysis. To evaluate c-Fos protein expres-
sion, two hours before perfusion, half of the mice in each group 
underwent magnetic stimulation for 180 s. As a control group, the 
other half of the mice were placed in the coil with no current run-
ning through the coil, exposing them only to the DC magnetic field 
of the permanent magnets. Sections belonging to three mice were 
excluded for IHC analysis of whole-brain rostrocaudal sections, as 
tissues were ruptured or damaged during tissue processing. In pre-
vious work, IHC quantification with a minimum of five subjects per 
group has been sufficient for valid analysis (48, 49).
Phase III: Behavioral testing
To evaluate the effect of MENP-induced neuronal modulation on 
brain tissue, two groups of animals were tested, and behavioral re-
sponses were evaluated. Mice were randomly assigned into two 
groups and received stereotactic injection of either MENPs (n = 9) 
or MSNPs (n = 8; 100 mg/ml). Following the recovery period of 
1-week postsurgery, animals were stimulated in the magnetic field, 
and behavioral testing was conducted. Specifically, animals were 
stimulated with either an AC and DC magnetic field (in the in vivo 
coil system with the coil on) or with only a DC magnetic field (in the 
in vivo coil system with the coil off). Measured behavioral parame-
ters were compared between the same mice following stimulation 
with an AC and DC magnetic field versus stimulation with only a 
DC magnetic field (fig. S4G).
Behavioral testing
CatWalk test
An automated gait analysis system CatWalk XT (Noldus 7.1, 
Wageningen, The Netherlands) was to evaluate motor behavior. 
The CatWalk consists of an enclosed walkway with a glass plate and 
a speed video recording camera (Fig. 3I). Gait performance was as-
sessed and recorded using the CatWalk analysis software. The glass 
plate was cleaned and dried before testing each subject to mini-
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stopping to smell or explore something during a run. In general, 
one successful test recording consisted of an average of five uninter-
rupted runs having a comparable running speed with a maximum 
variation of 30%. The experimenter and data analyst were blind to 
animal identity during the behavioral testing and data analysis. The 
following 20 static and dynamic parameters assessing individual 
paw functioning and gait patterns were analyzed: stance, mean in-
tensity, print area, print length, print width, swing mean, swing 
speed, stride length, maximum intensity at maximum contact, max-
imum intensity, minimum intensity, step cycle, duty cycle, regu-
larity index, base of support of the forelimbs, base of support of the 
hindlimbs, three limb support, speed, and cadence.
Rotarod test
An accelerating rotarod with a grooved rotating beam (3 cm) raised 
16 cm above a platform (model 47650, Ugo Basile Biological Research 
Apparatus, Italy) was used to measure coordination. The latency to 
fall off the rotating rod was recorded. Data were expressed as the 
mean value from three trials. Mice were subjected to four 300-s trials 
per day for three consecutive days (days 1 to 3) with an intertrial 
interval of ~15 min. Mice were forced to run on a rotating drum 
with speeds starting at 4 rpm and accelerating to 40 rpm within 300 s. 
Mice remaining on the beam during the full 300 s of the task were 
taken from the rotarod and given the maximum score. The experi-
menter and data analyst were blind to animal identity during the 
behavioral testing and data analysis.
Animal sacrifice protocol for IHC analysis of brain tissue
Mice were deeply anaesthetized with pentobarbital and transcardially 
perfused with tyrode buffer, followed by ice-cold 4% paraformalde-
hyde fixative in 0.1 M phosphate buffer. The brains were extracted 
from the crania and postfixed in 4% paraformaldehyde overnight 
and then submerged in sucrose for cryoprotection (24 hours in 
20% sucrose at 5°C). Coronal brain sections (20 m) were cut on a 
cryostat and stored at −80°C.
Immunohistochemistry
Tissue sections were incubated overnight with polyclonal rabbit 
antibodies raised against c-Fos protein (1:1000; Santa Cruz Biotech-
nology Inc.; sc-253), GFAP (1:1000; Dako; Z-033429), or Iba-1(1:1000; 
Wako; 016-26461). c-Fos IHC used biotinylated donkey anti-rabbit 
secondary antibody (1:400; Jackson ImmunoResearch Laboratories 
Inc.; 711065152) and avidin-biotin peroxidase complex (1:800; Elite 
ABC-kit, Vector Laboratories; PK-6100). The staining was visual-
ized by 3,3′-diaminobenzidine combined with NiCl2 intensification. 
GFAP and Iba-1 were visualized using immunofluorescence with 
donkey anti-rabbit Alexa 488 (1:100; Invitrogen; A-21206).
Quantification of c-Fos immunohistochemically labeled cells
Photographs of the stained motor cortex and thalamus sections from 
three rostrocaudal anatomical levels from bregma (AP: −0.58, −0.94, 
and −1.22) were taken at 10X magnification. We used Cell P soft-
ware (Olympus Soft Imaging Solutions, Münster, Germany) from 
an Olympus DP70 digital camera connected to an Olympus AX 70 
microscope (Olympus, Zoeterwoude, The Netherlands). In the im-
ages of the area of interest, the number of c-Fos–positive cells was 
counted using ImageJ software [version 1.52; National Institutes of 
Health (NIH), Bethesda, USA]. Cells immunopositive for c-Fos were 
counted manually, and the mean number of cells was corrected for 
surface area and expressed as cells per square millimeter. A cell was 
regarded positive when the intensity of the cell staining was signifi-
cantly higher than the surrounding background. The average value 
of three sections was used for statistical analysis in each subject. For 
the subthalamic area (the infusion site), a digital photograph was 
taken at one anatomical bregma (−2.06), and all c-Fos–positive cells 
within 1 mm2 of the injection site were counted.
Quantification of GFAP and Iba-1 immunohistochemically 
labeled cells
Photographs of the stained motor cortex and thalamus sections from 
three rostrocaudal anatomical levels from bregma (AP: −1.70, −2.06, 
and − 2.30) were taken at ×10 magnification. We used Cell P soft-
ware (Olympus Soft Imaging Solutions, Münster, Germany) from 
an Olympus DP70 digital camera connected to an Olympus AX 70 
microscope (Olympus, Zoeterwoude, The Netherlands). In the im-
ages of the area of interest, fluorescent density was measured using 
ImageJ software (version 1.52; NIH, Bethesda, USA). The average 
value of three sections was used for statistical analysis in each subject.
Quantification of MENP distribution and c-Fos expression 
volumes at the injection site
Stereological volume measurement was carried out on the MENP 
injection site at subthalamic region and surrounding c-Fos expres-
sion area. We used a stereological computer microscopy system (Stereo 
Investigator, Microbrightfield Bioscience, version 10, Williston, VT, 
USA). Briefly, after delineation of those regions in c-Fos–stained 
sections on video images displayed on the monitor, the volumes 
were calculated with Cavalieri’s principle (Cavalieri, 1635) (50). The 
volume of every part was calculated by multiplying the surface with 
the section thickness and the number of slices per series. Last, all 
these parts were summed, and the total volume of the MENP injec-
tion site and c-Fos expression area were calculated.
Statistical analysis
Unless otherwise indicated, data are presented as individual values 
with bars showing the means ± SD. The AC magnetic field magnitude 
and frequency dependence on MENP voltage output was determined 
using a linear regression, with coefficient of determination presented 
as R2. In vitro Ca2+ transient activity and in vivo c-Fos expression 
were analyzed using a one-way analysis of variance (ANOVA) with 
Tukey’s post-test to compare all groups (fig. S4). In vitro analysis of 
Ca2+ signaling with inhibitors was analyzed using a one-way ANOVA 
with Dunnett’s post-test, using drug-untreated cells as the controls. 
c-Fos protein expression in brain tissue was analyzed using an un-
paired t test. Changes in behavioral parameters in the same mice fol-
lowing stimulation with either a DC magnetic field or an AC and DC 
magnetic field were analyzed using a paired t test. The experimenter 
and data analyst were blind to animal identity during the behavioral 
testing, analysis of behavioral data, and quantification of IHC sections. 
P values of <0.05 were considered statistically significant in all cases.
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/7/3/eabc4189/DC1
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